PRMT1 and leukemia: Similar to Prmt1 in vivo knockdown data, the few leukemias from the mice that received Kdm4c-knockdown cells actually re-expressed high levels of Kdm4c and Hoxa9 (Figure S5H), indicating a strong growth disadvantage of Kdm4c knockdown leukemia cells.